Asset Details
Do you wish to reserve the book?
Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention
Do you wish to request the book?
Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention
2021
Overview
Melanoma and non-melanoma skin cancers (NMSCs) are the most frequent cancers of the skin in white populations. An increased risk in the development of skin cancers has been associated with the combination of several environmental factors (i.e., ultraviolet exposure) and genetic background, including melanocortin-1 receptor (MC1R) status. In the last few years, advances in the diagnosis of skin cancers provided a great impact on clinical practice. Despite these advances, NMSCs are still the most common malignancy in humans and melanoma still shows a rising incidence and a poor prognosis when diagnosed at an advanced stage. Efforts are required to underlie the genetic and clinical heterogeneity of melanoma and NMSCs, leading to an optimization of the management of affected patients. The clinical implications of the impact of germline MC1R variants in melanoma and NMSCs’ risk, together with the additional risk conferred by somatic mutations in other peculiar genes, as well as the role of MC1R screening in skin cancers’ prevention will be addressed in the current review.
Publisher
MDPI AG,MDPI
Subject
a-Melanocyte-stimulating hormone
/ alpha-melanocyte-stimulating hormone
/ Genetic Predisposition to Disease
/ Humans
/ Kinases
/ Melanoma
/ Mutation
/ Proteins
/ Receptor, Melanocortin, Type 1 - genetics
/ Receptor, Melanocortin, Type 1 - metabolism
/ Receptor, Melanocortin, Type 1 - physiology
/ Review
/ risk
